Form 10-Q Organogenesis Holdings For: Sep 30

Go back to Form 10-Q Organogenesis Holdings For: Sep 30

Oranogenesis Holdings (ORGO) PT Raised to $3.80 at Cantor Fitzgerald

November 13, 2024 7:16 AM EST

Cantor Fitzgerald analyst Ross Osborn raised the price target on Oranogenesis Holdings (NASDAQ: ORGO) to $3.80 (from $3.50) while maintaining a Overweight rating.

The analyst comments "We reiterate our Overweight and increase our 12-month price target to $3.80 from $3.50 on Organogenesis' ("ORGO") shares following the... More